| 000 | 01654 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517024730.0 | ||
| 264 | 0 | _c20160418 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1365-2222 | ||
| 024 | 7 |
_a10.1111/cea.12546 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOgese, M O | |
| 245 | 0 | 0 |
_aHLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis. _h[electronic resource] |
| 260 |
_bClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _cAug 2015 |
||
| 300 |
_a1305-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCystic Fibrosis _xgenetics |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA-DQ beta-Chains _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSulfamethoxazole _xadverse effects |
| 700 | 1 | _aSaide, K | |
| 700 | 1 | _aFaulkner, L | |
| 700 | 1 | _aWhitaker, P | |
| 700 | 1 | _aPeckham, D | |
| 700 | 1 | _aAlfirevic, A | |
| 700 | 1 | _aBaker, D M | |
| 700 | 1 | _aSette, A | |
| 700 | 1 | _aPirmohamed, M | |
| 700 | 1 | _aPark, B K | |
| 700 | 1 | _aNaisbitt, D J | |
| 773 | 0 |
_tClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology _gvol. 45 _gno. 8 _gp. 1305-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cea.12546 _zAvailable from publisher's website |
| 999 |
_c24782875 _d24782875 |
||